We break down the biggest diabetes tech and research highlights from the 2025 ADA Scientific Sessions. Justin is joined by CDCES Gary Scheiner to discuss new tubeless insulin pumps, an implantable continuous glucose monitor, and updates on a dual glucose-ketone sensor. We also explore cutting-edge research on islet cell therapies, ultra-concentrated insulins, and the potential of amylin as a complementary hormone treatment.   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Watch This Episode On Youtube   Join our Newsletter | Support us on Patreon    Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.